Optimus receives tentative approval from US FDA for generic Brexpiprazole tablets

Hyderabad/UNI: Optimus Pharma Private Limited Saturday announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the generic equivalent of Rexulti Tablets in the strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg of Otsuka Pharmaceutical Co. Ltd.

Granules USA recalls one batch of Naproxen Sodium 220 mg tablets

Hyderabad/UNI: The Granules USA, Inc, a wholly-owned foreign subsidiary of Granules India, has voluntarily recalled one batch of Naproxen Sodium 220 mg tablets at a retail level due to a minor ‘CGMP deviation’